Expression, purification, crystallization and preliminary X-ray diffraction analysis of a type II NADH:quinone oxidoreductase from the human pathogenStaphylococcus aureus
2015 ◽
Vol 71
(4)
◽
pp. 477-482
◽
In recent years, type II NADH dehydrogenases (NDH-IIs) have emerged as potential drug targets for a wide range of human disease causative agents. In this work, the NDH-II enzyme from the Gram-positive human pathogenStaphylococcus aureuswas recombinantly expressed inEscherichia coli, purified, crystallized and a crystallographic data set was collected at a wavelength of 0.873 Å. The crystals belonged to the orthorhombic space groupP212121, with unit-cell parametersa= 81.8,b= 86.0,c= 269.9 Å, contained four monomers per asymmetric unit and diffracted to a resolution of 3.32 Å. A molecular-replacement solution was obtained and model building and refinement are currently under way.
2014 ◽
Vol 70
(4)
◽
pp. 476-481
◽
2014 ◽
Vol 70
(2)
◽
pp. 256-259
◽
2016 ◽
Vol 72
(6)
◽
pp. 473-479
◽
Keyword(s):
2015 ◽
Vol 71
(4)
◽
pp. 397-400
◽
1999 ◽
Vol 55
(8)
◽
pp. 1487-1489
◽
1999 ◽
Vol 55
(2)
◽
pp. 554-556
◽
2014 ◽
Vol 70
(10)
◽
pp. 1421-1423
◽
2015 ◽
Vol 71
(2)
◽
pp. 243-246
◽